High Court Malm News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Opening remarks
During the second quarter of the fiscal year, Hamlet Pharma has made significant progress in its clinical trial program for Alpha1H, a drug candidate in the HAMLET family, as a standalone treatment for bladder cancer patients. The company has also continued its collaboration with Neurochase for the treatment of brain tumors with Alpha1H and its collaboration with Linnane Pharma, to define the potential of BAMLET as a drug candidate. ....

United States , Catharina Svanborg , Linnane Pharma , Helena Lomberg , Selectimmune Pharma , Martin Erixon , Salk Institute In La Jolla , Accelerator Fund , High Court Malm , Swedish Companies Registration Office Bolagsverket , Lund University , Neurochase Limited , Hamlet Pharma , Annual Peptide Therapeutics Symposium , Salk Institute , Cancer Therapy , Documented Clinical , Annual Report , Stock Market , Report July , Spotlight Stock Market , Annual General Meeting , Bill Hansson , Spotlight Stock , Generally Recognized As Safe , Swedish Companies Registration Office ,